Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818087 · ClinicalTrials.gov registry record
Elevate! : An Elderly Breast Cancer Cohort Study
A clinical trial of Breast Cancer, sponsored by Dana-Farber Cancer Institute.
- Active
- Registry status
- 253
- Enrollment target
- 4
- Study locations
NCT03818087: Active study of Breast Cancer, sponsored by Dana-Farber Cancer Institute.
NCT03818087 is a study of Breast Cancer that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 253 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818087, a study of Breast Cancer, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 253 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is focused on understanding how the investigators can improve upon breast cancer and health outcomes for older participants with breast cancer.
Primary Outcome
Report treatment recommendations made to patients enrolled on the cohort
Conditions Studied
Interventions
- BEHAVIORAL Observational cohort
Study Locations (4)
Massachusetts
- Brigham and Women Hospital - Boston
- Dana-Farber Cancer Institute - Boston
Maine
- Northern Light Cancer Care - Bangor
Rhode Island
- Lifespan Cancer Institute - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 253 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2028-11-01 |
What the registry record for NCT03818087 still lists
NCT03818087 is an observational study that tracks outcomes without assigning an intervention. The registered 253 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Observational cohort is the first listed.
NCT03818087 reports a single indexed study location in Massachusetts, Maine, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03818087 about?
NCT03818087 is a clinical study titled "Elevate! : An Elderly Breast Cancer Cohort Study". This study is focused on understanding how the investigators can improve upon breast cancer and health outcomes for older participants with breast cancer.
What is the current status of trial NCT03818087?
This trial is currently active not recruiting. The enrollment target is 253 participants. The study started on 2019-02-19. Estimated completion is 2028-11-01.
What conditions does trial NCT03818087 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT03818087?
The interventions under investigation include: Observational cohort (BEHAVIORAL).
Who is sponsoring clinical trial NCT03818087?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03818087 being conducted?
This trial has 4 study locations across Maine, Massachusetts, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03818087's enrollment target sits among peer trials
253 320th of 1224 higher than 904 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04390737 · 254 participants · Phase 1
Evaluate the Safety and Clinical Activity of HH2853
- NCT04677647 · 254 participants · NA
OurChild: A Health IT Solution to Reduce Minority Health Disparities
- NCT05503797 · 254 participants · Phase 2
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- NCT06167317 · 254 participants · Phase 1
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI